Browsing Tag

Partnering

580 posts

AstraZeneca, Silence Therapeutics in $2.0-Bn Deal for siRNA Therapeutics
By

By
AstraZeneca has formed a collaboration with Silence Therapeutics, a London-based biopharmaceutical, to discover, develop and commercialize small interfering RNA (siRNA) therapeutics for treating cardiovascular, renal, metabolic and respiratory diseases, in…

Pharma Companies Join Gates Foundation in Consortium for COVID-19
By

By
Fifteen pharma companies have formed a consortium with the COVID-19 Therapeutics Accelerator, launched by the Bill & Melinda Gates Foundation, to fasten COVID treatments.   A consortium of 15 pharmaceutical…

Pfizer Outlines Five-Point Plan for Combating COVID-19
By

By
Pfizer has issued a five-point plan for its collaboration with industry and government on R&D and manufacturing for vaccines and treatments against the novel coronavirus (COVID-19).  “In this troubling time,…

Sanofi, Regeneron Begin Clinical Trial for Antiviral Kevzara for Coronavirus
By

By
Sanofi and Regeneron Pharmaceuticals, Inc., a Tarrytown, New York-based biopharmaceutical company, have started a clinical program evaluating Kevzara (sarilumab), an antiviral compound, in patients hospitalized with severe COVID-19 (the novel…

Novartis Forms $20-M COVID-19 Response Fund; Collaborates in EU Research Pact
By

By
Novartis has announced funding and research projects relating to the novel coronavirus (COVID-19), including the creation of a $20-million global fund to support communities impacted by the COVID-19 pandemic, and…

Lilly, AbCellera To Develop Antibody Therapeutics Against COVID-19
By

By
Eli Lilly and Company and AbCellera, a Vancouver, British Columbia, Canada-based biopharmaceutical company, have formed an agreement to co-develop antibody products for the treatment and prevention of COVID-19, the disease…

Biogen, Sangamo in $2.72-Bn Deal for Gene-Regulation Therapies in Neurology
By

By
Biogen and Sangamo Therapeutics, a genomic medicine company, have formed a global licensing collaboration agreement for gene-regulation therapies in neurology in a deal worth up to $2.72 billion ($350 million…

Global Pharma Briefs: News from Asia, Europe and the US
By

By
A roundup of developments from Malaysia (Biocon), Saudi Arabia (Grifols), UK (AstraZeneca), and the US (Merck & Co., Taro Pharmaceuticals). Malaysia Biocon Receives FDA Form 483 for Insulin Mfg Plant…

GSK, Immatics Partner to Develop Adoptive Cell Therapies in $600-M-Plus Pact
By

By
Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company for T-cell redirecting cancer immunotherapies, has entered into a strategic collaboration agreement with GlaxoSmithKline (GSK) to develop novel adoptive cell therapies targeting multiple…

Gilead Sciences, GSK, Moderna Advance Treatments Against Coronavirus
By

By
Gilead initiates Phase III studies for remdesivir, an investigational antiviral drug, Moderna ships batch of vaccine for Phase I study, and GSK provides adjuvants. Gilead Sciences Initiates Studies of Investigational…